Which is safer: ALL or CIPLA.NS?
Safety has three computed layers here: business quality (ALL 100/100 vs CIPLA.NS —/100), signal maturity (270 vs 90 bars), and your position sizing — which only you control. We publish the pieces and the method, not a single verdict.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| ALL (Allstate) | CIPLA.NS (Cipla) | |
| Market / sector | us · Financials | in · Pharma |
| Price | $257.62 | ₹1,407 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 270 bars · uPnL +26.8% | LONG · 90 bars · uPnL +7.7% |
| Total return | +26.8% | +3.1% |
Cite this page
Balance Labs Research Desk (2026-09-01). "Which is safer: ALL or CIPLA.NS?." balancelabs.app · https://balancelabs.app/stocks/compare/all-vs-cipla.ns/q/all-or-cipla.ns-safer · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← ALL vs CIPLA.NS · snapshot 2026-09-01 · not investment advice